Provider lobbies are praising bipartisan legislation that would waive the cost-sharing for chronic care management (CCM) services that the groups say create barriers for patients.
FREE TRIAL Receive 30 days of no-obligation access. SIGN UP
Home
Top Story
Murphy Bill Would Close Key TrumpRx Gap By Requiring DTC Prices Count Toward Deductibles
A House Ways & Means Republican introduced legislation Tuesday that would significantly boost the cost-saving potential of TrumpRx by requiring cash prices patients pay for drugs on direct-to-consumer platforms count towards deductibles and out-of-pocket maximums in private plans.
Spotlight On MAHA
Poll: MAHA Agenda Risky With Key Voters For GOP In Swing Districts
A new poll suggests the “Make America Healthy Again” movement may be losing traction among key voters in competitive congressional districts across the country, with support eroding most sharply among independents and a bloc of voters who are sympathetic the movement’s goals but remain uneasy with its leadership and policy direction -- potentially making alignment with HHS Secretary Robert F. Kennedy Jr. a risk for Republicans in the upcoming midterm elections.
Addition Of ACIP Liaison Groups Is Latest Vaccine Debate Flashpoint
Latest News
The National Alliance of Healthcare Purchaser Coalitions, Small Business Majority and Families USA want lawmakers to pass legislation that would ensure patients are immediately made aware of the real costs of treatments and prescription drugs, while also requiring patient costs and provider reimbursement be similar across all outpatient settings.
Virginia Gov. Abigail Spanberger (D) has put a major crimp in the state’s closely watched prescription drug affordability board (PDAB) legislation: She is requiring the state legislature vote again when it reconvenes in 2027 on a key provision that lets the board tie drug price caps in Virginia to the maximum fair prices in CMS’ Medicare drug price negotiation program.
FDA is moving to use a broader approach to dietary supplement regulation that would allow manufacturers to more easily market substances like peptides, but some stakeholders are concerned moving away from the traditional framework would blur the lines between supplements and drugs.
CMS officials have begun pointing to Medicare Advantage (MA) as a model for their new Long-term Enhanced ACO Design (LEAD) framework, repeatedly comparing the new CMS Innovation Center (CMMI) model to MA and highlighting tools that mirror benefits traditionally offered by these private plans.
Medicare Advantage patients should be included in some of the quality measures inpatient hospitals report to CMS, the Trump administration says in the proposed fiscal 2027 hospital inpatient pay rule, which would add several new quality reporting program measures while eliminating the measure for long term care hospitals to report how many health care personnel and patients have received a COVID-19 vaccine.